Investing.com - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Merck, Box Rise Premarket; Salesforce Falls

Published 12/01/2021, 08:05 AM
Updated 12/01/2021, 08:06 AM
© Reuters

By Peter Nurse 

Investing.com -- Stocks in focus in premarket trade on Wednesday, December 1st. Please refresh for updates.

  • Salesforce (NYSE:CRM) stock fell 6.5% after the software company provided disappointing current-quarter profit guidance in the face of stiff competition from rivals including Microsoft (NASDAQ:MSFT). 

  • Merck (NYSE:MRK) stock rose 0.8% after a panel of advisers to the U.S. Food and Drug Administration voted to recommend the agency authorize the drugmaker's antiviral pill to treat Covid-19.

  • Box (NYSE:BOX) stock rose 9.3% after the software company beat quarterly  expectations on both the top and bottom lines, helped by its performance in the Content Cloud market.

  • American Airlines (NASDAQ:AAL) stock rose 1.6%, Delta (NYSE:DAL) stock rose 2.2% and United (NASDAQ:UAL) stock rose 1.8% as the airlines rebounded, while cruise operators Norwegian Cruise Line (NYSE:NCLH), Carnival (NYSE:CUK) and Royal Caribbean (NYSE:RCL) all rose more than 2.5%.

  • Exxon Mobil (NYSE:XOM) stock rose 1.9%, Chevron (NYSE:CVX) stock climbed 2% and Occidental Petroleum (NYSE:OXY) stock rose 3.9% as crude prices soared more than 4%.

  • Allbirds (NASDAQ:BIRD) stock fell 4.7% after the shoe retailer reported a wider loss despite a 33% jump in quarterly sales.

  • Hewlett Packard Enterprise (NYSE:HPE) stock fell 1.4% after the information technology company topped profit expectations for its fiscal fourth-quarter earnings but issued first quarter earnings guidance that looked light.

  • Ambarella (NASDAQ:AMBA) stock rose 15% after the semiconductor maker released a better-than-expected quarterly report, helped by strong sales of its computer-vision chips. 

  • Lennar (NYSE:LEN) stock rose 3.8% after Goldman Sachs upgraded its investment stance on the real estate company to ‘buy’ from ‘neutral’, seeing 33% upside, thanks to sustained strong demand for new homes in the U.S.

  • DR Horton (NYSE:DHI) stock fell 0.1% after Goldman downgraded its stance on the home construction company to ‘neutral’ from ‘buy’, saying upside in this stock is now limited.

 

Latest comments

What a surprise...Yet another loss reversed the day after it occurs.  The laughingstock of the financial world can "rally" for days on end, but single day losses are now the norm.  Let's criminally inflate equities so they can be unloaded on retirement plans.  Assume the proper position America, the Wall Street FRAUD continues.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.